10.28
Phreesia Inc stock is traded at $10.28, with a volume of 602.30K.
It is up +0.39% in the last 24 hours and down -11.23% over the past month.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
See More
Previous Close:
$10.24
Open:
$10.19
24h Volume:
602.30K
Relative Volume:
0.69
Market Cap:
$638.09M
Revenue:
$495.59M
Net Income/Loss:
$9.18M
P/E Ratio:
69.04
EPS:
0.1489
Net Cash Flow:
$57.92M
1W Performance:
+1.08%
1M Performance:
-11.23%
6M Performance:
-8.13%
1Y Performance:
-55.84%
Phreesia Inc Stock (PHR) Company Profile
Name
Phreesia Inc
Sector
Industry
Phone
888-654-7473
Address
1521 CONCORD PIKE, WILMINGTON
Compare PHR vs VEEV, TEM, BTSG, TXG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PHR
Phreesia Inc
|
10.28 | 639.95M | 495.59M | 9.18M | 57.92M | 0.1489 |
|
VEEV
Veeva Systems Inc
|
263.75 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
80.36 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
56.60 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TXG
10 X Genomics Inc
|
76.97 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HQY
Healthequity Inc
|
94.51 | 7.96B | 1.34B | 230.70M | 440.96M | 2.6695 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| Mar-31-26 | Downgrade | Citigroup | Buy → Neutral |
| Mar-31-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-31-26 | Reiterated | Needham | Buy |
| Mar-31-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-31-26 | Downgrade | Truist | Buy → Hold |
| Jan-09-26 | Resumed | RBC Capital Mkts | Outperform |
| Jan-09-26 | Initiated | Wells Fargo | Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-05-25 | Resumed | DA Davidson | Buy |
| Aug-27-25 | Initiated | Mizuho | Outperform |
| Jan-08-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-26-24 | Initiated | Truist | Buy |
| Jan-17-24 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Jan-04-23 | Reiterated | Needham | Buy |
| Dec-13-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-13-22 | Initiated | DA Davidson | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Jan-06-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-02-21 | Reiterated | Needham | Buy |
| Aug-27-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-08-21 | Initiated | Berenberg | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Apr-01-21 | Initiated | Robert W. Baird | Outperform |
| Nov-11-20 | Initiated | Stephens | Overweight |
| Oct-27-20 | Initiated | Needham | Buy |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Jul-14-20 | Initiated | Citigroup | Neutral |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Jan-31-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-09-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-19 | Initiated | Raymond James | Outperform |
| Oct-11-19 | Initiated | Robert W. Baird | Outperform |
| Aug-13-19 | Initiated | JP Morgan | Overweight |
| Aug-12-19 | Initiated | Piper Jaffray | Overweight |
| Aug-12-19 | Initiated | Wells Fargo | Outperform |
| Aug-12-19 | Initiated | William Blair | Outperform |
| Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
View All
Phreesia Inc Stock (PHR) Latest News
Phreesia Cuts Debt as Profitability Improves in Fiscal Q2 - MyChesCo
Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base - Yahoo Finance
Phreesia, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsPHR - Eastern Progress
Phreesia Inc Profile: Recipients - OpenSecrets
PHREESIA, INC. : RAYMOND JAMES CUTS TO MARKET PERFORM FROM OUTPERFORM - webull.com
Phreesia (PHR) Q2 2027 Earnings Call Transcript - The Globe and Mail
Why Phreesia Stock Got Knocked Down Today - The Motley Fool
Why Phreesia Stock Got Knocked Down Today - The Motley Fool
PHR Downgraded by Raymond James -- Rating Changed to Market Perf - GuruFocus
Raymond James downgrades Phreesia stock rating on slowing growth - Investing.com
Raymond James downgrades Phreesia stock rating on slowing growth By Investing.com - Investing.com India
Phreesia, Inc. 2027 Q2ResultsEarnings Call Presentation (NYSE:PHR) 2026-09-07 - Seeking Alpha
ETFs Investing in Phreesia, Inc. Stocks - TradingView
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Encourages Phreesia, Inc. (PHR) Stockholders to Inquire about Securities Investigation | NYSE:PHR | Press Release - Stockhouse
Needham Reiterates Buy on Phreesia, Maintains $14 Price Target - scanx.trade
Hoffman Allison C Reports Ownership of 266,574 Phreesia Shares Following September 1 Award - Kalkine Media
Linetsky David Receives 202,000 Phreesia Shares in Insider Award Transactions - Kalkine Media
DA Davidson cuts Phreesia stock price target on revenue assumptions By Investing.com - Investing.com South Africa
PHR Maintained by Baird -- Price Target Raised to $11.00 - GuruFocus
DA Davidson cuts Phreesia stock price target on revenue assumptions - investing.com
Citizens maintains Phreesia stock rating after mixed results By Investing.com - Investing.com Australia
Citizens maintains Phreesia stock rating after mixed results - investing.com
Phreesia's Catalyst for Q3 Is Performance of Network Solutions Business, RBC Says - Moomoo
Phreesia Swings to Operating Profit in Q2, Revenue Up 10.4% - Minichart
Equity grant boosts Phreesia (PHR) accounting chief's stake - Stock Titan
New 192,000-share stock grant for Phreesia (NYSE: PHR) executive - Stock Titan
Phreesia (PHR) gives president Evan Roberts 192,000 RSUs with five-year vesting - Stock Titan
Phreesia (PHR) awards CEO 500,000 RSUs vesting from 2027 - Stock Titan
Phreesia (PHR) Stock Sinks As Profit Streak Fails To Lift Confidence - simplywall.st
Why Phreesia Stock Tumbled Today - finance.yahoo.com
Phreesia, Inc. 2026: Revenue $129.46M, EPS $0.03— 10-Q Summary - TradingView
Phreesia (PHR) swings to first-half profit and stronger cash flow - Stock Titan
Tranche Update on Phreesia, Inc.'s Equity Buyback Plan announced on March 13, 2025. - marketscreener.com
Wells Fargo raises Phreesia stock price target on network growth By Investing.com - Investing.com South Africa
Phreesia Inc. (PHR) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Phreesia Shares Sink After 2Q Earnings Underwhelm - Moomoo
Phreesia Falls Short on Q2 2027: $0.03 EPS vs $0.09 Expected - AlphaStreet
Phreesia's Catalyst for Q3 is Performance of Network Solutions Business, RBC Says - marketscreener.com
Phreesia Releases Q2 2027 Financial Results - AlphaStreet
PHR Maintained by Wells Fargo -- Price Target Raised to $10.00 - GuruFocus
These Analysts Revise Their Forecasts On Phreesia After Q2 Results - Benzinga
PHR Maintained by Canaccord Genuity -- Price Target Stays at $16 - GuruFocus
Phreesia, Inc. Q2 2027 Earnings Call Summary - Yahoo Finance
PHR Reiterated by Needham -- Price Target Maintained at $14.00 - GuruFocus
Wells Fargo raises Phreesia stock price target on network growth - Investing.com
Phreesia Inc (PHR) (Q2 2027) Earnings Call Highlights: Record EB - GuruFocus
Bernstein Liebhard probes Phreesia for potential fiduciary duty breaches - scanx.trade
Phreesia Q2 FY2027 slides: revenue up 10%, shares fall on EPS miss - Investing.com Nigeria
PHR Looks 56.4% Undervalued on GF Value™ - GuruFocus
Phreesia (PHR) Fiscal Q2 2027 Earnings Call: EBITDA Reaches $32.9M, Guidance Maintained - TradingKey
Phreesia Inc Stock (PHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):